Sotera Health Reports Q2 2024 Earnings

authorIntellectia.AI2024-08-06
7
SHC.O
Illustration by Intellectia.AI

Sotera Health Reports Q2 2024 Earnings

Sotera Health Company has released its financial results for the second quarter ending June 30, 2024.

Key Financial Metrics

Metric Q2 2024 Q1 2024 Q2 2023 YoY Change (%) QoQ Change (%)
Total Revenue $276.6 million $248.2 million $255.3 million 8.3% 11.4%

Interpretation: Sotera Health's total revenue for Q2 2024 increased by 8.3% year-over-year (YoY) and 11.4% quarter-over-quarter (QoQ). However, earnings per share (EPS) data and consensus estimates are not provided.

Revenue Performance by Segment

Segment Q2 2024 Revenue Q2 2023 Revenue YoY Change (%)
Sterigenics $176.4 million $166.6 million 5.9%
Nordion $41.2 million $31.9 million 29.0%
Nelson Labs $59.0 million $56.7 million 4.0%

Interpretation: The Sterigenics segment reported a 5.9% increase in revenue YoY, Nordion saw a significant 29.0% revenue increase, and Nelson Labs had a 4.0% rise in revenue YoY. Information for QoQ comparisons and revenue guidance is not provided.

Stock Price Movement

Date of Earnings Release Stock Price % Change Since Release
After event +7.53%

Interpretation: Following the earnings release, the company's stock price increased by approximately 7.53%.

Summary: Sotera Health reported a strong Q2 2024 with a notable increase in total revenue and significant growth in key segments, particularly Nordion. Despite lacking details on EPS, operational data, forward guidance, and commentary from officers, the company's stock responded positively, reflecting investor confidence.

Share